Independent research on the U.S. markets, Baptista Research

Baptista Research

Independent research on the U.S. markets

Baptista Research is an independent financial research house focused on the U.S. markets. We provide equity research as well as credit research reports on the top-listed U.S. companies with most of our focus on technology, consumer goods and services, automobiles, industrials, oil and gas, pharma, and healthcare. Our research has served more than 3000 institutional investors including mutual funds, hedge funds, banks, family offices, and various buy-side firms. We operate a research subscription service where institutions, as well as retail investors, can have priority access to all our research. We also have a wide distribution of our research reports across some of the top global financial platforms. Apart from equity research and credit research, we also provide advisory services with respect to mergers & acquisitions (M&A), private equity/ venture capital fundraising, valuation reports, and investment management services for corporates.
Baptista Research is owned and managed by Ishan Majumdar, an ex-Venture Capitalist/ Investment Banker, a Chartered Accountant, and a Masters’ degree holder in Management from HEC Paris. Ishan has nearly a decade of experience in Mergers and Acquisitions, Leveraged Buyouts (LBOs), Venture Capital Investing, Corporate Strategy, and Valuation in front-office roles at the likes of BNP Paribas CIB, Credit Agricole CIB, Groupe Danone, and TIW Private Equity. He has worked on and closed multiple acquisition deals, leveraged buyouts, and start-up investment transactions.

Equity Bottom-Up

<ul><li>Microchip Technology Inc.'s first quarter fiscal year 2025 earnings call outlined a series of financial metrics and strategic directions that indicate both strengths and challenges for the company.</li><li>In the reported quarter, net sales amounted to $1.241 billion, marking a sequential decrease of 6.4%.</li><li>This decline reflects an ongoing adjustment to an inventory correction phase that the semiconductor industry is experiencing.</li></ul>

Microchip Technology Inc.'s first quarter fiscal year 2025 earnings call outlined a series of financial metrics and strategic directions that indicate both strengths and challenges for the company.In the reported quarter, net sales amounted to $1.241 billion, marking a sequential decrease of 6.4%.This decline reflects an ongoing adjustment to an inventory correction phase that the semiconductor industry is experiencing.

Microchip Technology: Strategic Approach To Premium Drilling Locations & Critical Growth Drivers

Covering IPOs, Healthcare and Technology Stocks

Andrei Zakharov

Equity Capital Markets

Horizon Robotics / Equity Capital Markets

<ul>
<li>Horizon Robotics, a leading provider of ADAS and AD solutions for passenger vehicles, plans to raise up to $500M in Hong Kong IPO.</li>
<li>I expect Horizon Robotics will price its IPO below last round valuation of ~$8.7B as revenue growth will slow below 50% y/y in 2024, down from 71% y/y in 2023.</li>
<li>The company’s key competitors, including Mobileye and Microchip Technology, revised their revenue guidance downwards for the second half of 2024.</li>
</ul>


Horizon Robotics, a leading provider of ADAS and AD solutions for passenger vehicles, plans to raise up to $500M in Hong Kong IPO.
I expect Horizon Robotics will price its IPO below last round valuation of ~$8.7B as revenue growth will slow below 50% y/y in 2024, down from 71% y/y in 2023.
The company’s key competitors, including Mobileye and Microchip Technology, revised their revenue guidance downwards for the second half of 2024.


Horizon Robotics IPO: High Valuation Is At Risk As NEV Production Forecasts Have Weakened

Korea/Asia, Events, IPOs, Douglas Research Advisory

Douglas Kim

Korea/Asia, Events, IPOs

<ul>
<li>Our base case valuation is market cap of US$5.4 billion or target price of US$35.9 per share, which is 20% higher than high end of the IPO price range (US$30).</li>
<li>We estimate Astera Labs (ALAB US) to generate revenue of $221.3 million (up 91.1% YoY) in 2024 and $304.5 million (up 37.5% YoY) in 2025.</li>
<li>Many investors are willing to take extra risk to invest in companies such as Astera Labs that could generate strong sales growth amid rush to aggressively expand AI capabilities.</li>
</ul>


Our base case valuation is market cap of US$5.4 billion or target price of US$35.9 per share, which is 20% higher than high end of the IPO price range (US$30).
We estimate Astera Labs (ALAB US) to generate revenue of $221.3 million (up 91.1% YoY) in 2024 and $304.5 million (up 37.5% YoY) in 2025.
Many investors are willing to take extra risk to invest in companies such as Astera Labs that could generate strong sales growth amid rush to aggressively expand AI capabilities.


<ul>
<li>Astera Labs (ALAB US) is scheduled to debut its IPO on 20 March. The company is offering 17.8 million shares at a price of $27 to $30 per share. </li>
<li>Founded in 2017, Astera Labs is a fabless semiconductor company headquartered in Silicon Valley. The company designs and sells semiconductor technology, but the production is outsourced.</li>
<li>Astera Labs' major competitors include Montage Technology (688008 CH), Parade Technologies (4966 TT), Broadcom (AVGO US), Credo Technology Group Holding (CRDO US), and Marvell Technology (MRVL US).</li>
</ul>


Astera Labs (ALAB US) is scheduled to debut its IPO on 20 March. The company is offering 17.8 million shares at a price of $27 to $30 per share. 
Founded in 2017, Astera Labs is a fabless semiconductor company headquartered in Silicon Valley. The company designs and sells semiconductor technology, but the production is outsourced.
Astera Labs' major competitors include Montage Technology (688008 CH), Parade Technologies (4966 TT), Broadcom (AVGO US), Credo Technology Group Holding (CRDO US), and Marvell Technology (MRVL US).


<ul>
<li>Astera Labs, a cloud- and AI connectivity-focused semiconductor company, filed to go public. Top-tier underwriters Morgan Stanley and J.P. Morgan are leading the offering.</li>
<li>The fabless semiconductor unicorn plans to raise up to $500M. Selling stockholders intend to sell shares and the number of shares is yet to be announced.</li>
<li>I like the long-term, AI/cloud story. However, the IPO may look too pricey at more than $3B valuation despite the company’s revenue acceleration and improving profitability.</li>
</ul>


Astera Labs, a cloud- and AI connectivity-focused semiconductor company, filed to go public. Top-tier underwriters Morgan Stanley and J.P. Morgan are leading the offering.
The fabless semiconductor unicorn plans to raise up to $500M. Selling stockholders intend to sell shares and the number of shares is yet to be announced.
I like the long-term, AI/cloud story. However, the IPO may look too pricey at more than $3B valuation despite the company’s revenue acceleration and improving profitability.


Astera Labs IPO Preview and Valuation Analysis: Will Pricey IPO Frighten The Investors Off?

United States

Microchip Technology Incorporated designs, manufactures, and markets microcontrollers, related mixed-signal and memory products, and application development systems for high-volume embedded control applications. The Company also designs, develops, and markets linear/mixed-signal, power management, and thermal management products.

Price Gauge
52-week Range	0.00 - 0.00
Market Cap (USDm)	0.00
P/E	0.00
Dividend (Yield)	0.00

Microchip Technology (MCHP US)

Microchip Technology: Strategic Approach To Premium Drilling Locations & Critical Growth Drivers

Microchip Technology Inc.'s first quarter fiscal year 2025 earnings call outlined a series of financial metrics and strategic directions that...

Baptista Research

Horizon Robotics IPO: High Valuation Is At Risk As NEV Production Forecasts Have Weakened

In my insight, I discuss valuation framework for comparable company analysis and explain why high valuation of Horizon Robotics may be at risk

Andrei Zakharov

Astera Labs IPO Valuation Analysis

Our base case valuation of Astera Labs is market cap of US$5.4 billion or target price of US$35.9 per share, which is 20% higher than high end of...

Douglas Kim

Astera Labs IPO Preview

Astera Labs (ALAB US) is scheduled to debut its IPO on 20 March. The company is offering 17.8 million shares at a price of $27 to $30 per share.

Douglas Kim

Astera Labs IPO Preview and Valuation Analysis: Will Pricey IPO Frighten The Investors Off?

California-based Astera Labs has filed for an IPO and plans to raise up to $500M. The fabless semiconductor unicorn may be valued at more than $3B,...

Andrei Zakharov

Price Gauge

52-week Range

Market Cap (USDm)

P/E

Dividend (Yield)